nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—ADRA1D—Signaling Pathways—RDH8—age related macular degeneration	0.00154	0.00154	CbGpPWpGaD
Norepinephrine—ADRA2B—G alpha (i) signalling events—C3—age related macular degeneration	0.0015	0.0015	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—NMNAT1—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—RHO—age related macular degeneration	0.00148	0.00148	CbGpPWpGaD
Norepinephrine—SLC6A2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00147	0.00147	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—RHO—age related macular degeneration	0.00146	0.00146	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—RHO—age related macular degeneration	0.00146	0.00146	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—RHO—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—RHO—age related macular degeneration	0.00144	0.00144	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—RHO—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—RDH8—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Norepinephrine—ADRA2C—G alpha (i) signalling events—C3—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—ELOVL4—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—RDH8—age related macular degeneration	0.00139	0.00139	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—RDH8—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—ELOVL4—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—RHO—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—RHO—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—RPE65—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—RHO—age related macular degeneration	0.00133	0.00133	CbGpPWpGaD
Norepinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—ELOVL4—age related macular degeneration	0.0013	0.0013	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—RDH8—age related macular degeneration	0.0013	0.0013	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—RHO—age related macular degeneration	0.0013	0.0013	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—RDH8—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Norepinephrine—DRD2—G alpha (i) signalling events—C3—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Norepinephrine—ADRA2A—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—NMNAT1—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—RPE65—age related macular degeneration	0.00123	0.00123	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—RHO—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Norepinephrine—PAH—Disease—APOE—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—RPE65—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR ligand binding—CCL2—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—RHO—age related macular degeneration	0.0012	0.0012	CbGpPWpGaD
Norepinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.0012	0.0012	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—RPE65—age related macular degeneration	0.0012	0.0012	CbGpPWpGaD
Norepinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Norepinephrine—SLC22A2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—RDH8—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Norepinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—RHO—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Norepinephrine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Norepinephrine—PAH—Metabolism—CD36—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Norepinephrine—ADRA2A—G alpha (i) signalling events—C3—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—RDH8—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—RPE65—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—SLC16A8—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—RPE65—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Norepinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Norepinephrine—SLC22A1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—ELOVL4—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Norepinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—RHO—age related macular degeneration	0.00109	0.00109	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—SLC16A8—age related macular degeneration	0.00109	0.00109	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—ABCA4—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—RDH8—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—SLC16A8—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Norepinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—RPE65—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Norepinephrine—PAH—Metabolism—APOE—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Norepinephrine—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR ligand binding—C3—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—RPE65—age related macular degeneration	0.000992	0.000992	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—ABCA4—age related macular degeneration	0.000988	0.000988	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—ABCA4—age related macular degeneration	0.000979	0.000979	CbGpPWpGaD
Norepinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.000974	0.000974	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—ABCA4—age related macular degeneration	0.000967	0.000967	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—RHO—age related macular degeneration	0.000944	0.000944	CbGpPWpGaD
Norepinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000942	0.000942	CbGpPWpGaD
Norepinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000934	0.000934	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—RPE65—age related macular degeneration	0.000922	0.000922	CbGpPWpGaD
Norepinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000922	0.000922	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—LIPC—age related macular degeneration	0.000918	0.000918	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR ligand binding—C3—age related macular degeneration	0.000917	0.000917	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—ABCA4—age related macular degeneration	0.000915	0.000915	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR ligand binding—C3—age related macular degeneration	0.000909	0.000909	CbGpPWpGaD
Norepinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.000905	0.000905	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—ABCA4—age related macular degeneration	0.0009	0.0009	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR ligand binding—C3—age related macular degeneration	0.000897	0.000897	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—SLC16A8—age related macular degeneration	0.000889	0.000889	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—CETP—age related macular degeneration	0.000886	0.000886	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR downstream signaling—C3—age related macular degeneration	0.000873	0.000873	CbGpPWpGaD
Norepinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000872	0.000872	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—RHO—age related macular degeneration	0.00086	0.00086	CbGpPWpGaD
Norepinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000858	0.000858	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—CD36—age related macular degeneration	0.000857	0.000857	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—RHO—age related macular degeneration	0.000852	0.000852	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR ligand binding—C3—age related macular degeneration	0.000849	0.000849	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—RHO—age related macular degeneration	0.000841	0.000841	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR ligand binding—C3—age related macular degeneration	0.000835	0.000835	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ABCA4—age related macular degeneration	0.00083	0.00083	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000813	0.000813	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—CD36—age related macular degeneration	0.000801	0.000801	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ABCA4—age related macular degeneration	0.0008	0.0008	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—RHO—age related macular degeneration	0.000796	0.000796	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—C3—age related macular degeneration	0.000793	0.000793	CbGpPWpGaD
Norepinephrine—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000792	0.000792	CbGpPWpGaD
Norepinephrine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000791	0.000791	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR ligand binding—CCL2—age related macular degeneration	0.000788	0.000788	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—RHO—age related macular degeneration	0.000783	0.000783	CbGpPWpGaD
Norepinephrine—DRD2—GPCR ligand binding—C3—age related macular degeneration	0.00077	0.00077	CbGpPWpGaD
Norepinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000762	0.000762	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ABCA4—age related macular degeneration	0.000743	0.000743	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—C3—age related macular degeneration	0.000742	0.000742	CbGpPWpGaD
Norepinephrine—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00074	0.00074	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—SQSTM1—age related macular degeneration	0.000737	0.000737	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—RHO—age related macular degeneration	0.000722	0.000722	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR ligand binding—CCL2—age related macular degeneration	0.000718	0.000718	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR ligand binding—CCL2—age related macular degeneration	0.000711	0.000711	CbGpPWpGaD
Norepinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000708	0.000708	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR ligand binding—CCL2—age related macular degeneration	0.000702	0.000702	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	0.000696	0.000696	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—RHO—age related macular degeneration	0.000696	0.000696	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—C3—age related macular degeneration	0.000689	0.000689	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR ligand binding—CCL2—age related macular degeneration	0.000664	0.000664	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR ligand binding—CCL2—age related macular degeneration	0.000654	0.000654	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—CD36—age related macular degeneration	0.000651	0.000651	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—RHO—age related macular degeneration	0.000646	0.000646	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—CCL2—age related macular degeneration	0.00062	0.00062	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.000609	0.000609	CbGpPWpGaD
Norepinephrine—DRD2—GPCR ligand binding—CCL2—age related macular degeneration	0.000603	0.000603	CbGpPWpGaD
Norepinephrine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000601	0.000601	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—CCL2—age related macular degeneration	0.000581	0.000581	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—LIPC—age related macular degeneration	0.000576	0.000576	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—C3—age related macular degeneration	0.000569	0.000569	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000564	0.000564	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—LIPC—age related macular degeneration	0.00056	0.00056	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—CETP—age related macular degeneration	0.000555	0.000555	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000544	0.000544	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—CETP—age related macular degeneration	0.00054	0.00054	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000539	0.000539	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—LIPC—age related macular degeneration	0.000537	0.000537	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—CD36—age related macular degeneration	0.000532	0.000532	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TGFBR1—age related macular degeneration	0.00053	0.00053	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—C3—age related macular degeneration	0.000518	0.000518	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—CETP—age related macular degeneration	0.000518	0.000518	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—C3—age related macular degeneration	0.000516	0.000516	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—C3—age related macular degeneration	0.000513	0.000513	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—C3—age related macular degeneration	0.000507	0.000507	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.000491	0.000491	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000483	0.000483	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SQSTM1—age related macular degeneration	0.00048	0.00048	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—C3—age related macular degeneration	0.00048	0.00048	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000478	0.000478	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000472	0.000472	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—C3—age related macular degeneration	0.000472	0.000472	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—C3—age related macular degeneration	0.000471	0.000471	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—APOE—age related macular degeneration	0.00047	0.00047	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—C3—age related macular degeneration	0.000468	0.000468	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—C3—age related macular degeneration	0.000466	0.000466	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—C3—age related macular degeneration	0.00046	0.00046	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—LIPC—age related macular degeneration	0.000455	0.000455	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000447	0.000447	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TGFBR1—age related macular degeneration	0.00044	0.00044	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CETP—age related macular degeneration	0.000439	0.000439	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000438	0.000438	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—APOE—age related macular degeneration	0.000436	0.000436	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—C3—age related macular degeneration	0.000436	0.000436	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—C3—age related macular degeneration	0.000435	0.000435	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000434	0.000434	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—C3—age related macular degeneration	0.000429	0.000429	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000428	0.000428	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—KDR—age related macular degeneration	0.000427	0.000427	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—C3—age related macular degeneration	0.000419	0.000419	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—VEGFA—age related macular degeneration	0.000408	0.000408	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000405	0.000405	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.000405	0.000405	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—CCL2—age related macular degeneration	0.000404	0.000404	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000399	0.000399	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—C3—age related macular degeneration	0.000395	0.000395	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000391	0.000391	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—C3—age related macular degeneration	0.00039	0.00039	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—VEGFA—age related macular degeneration	0.000381	0.000381	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—C3—age related macular degeneration	0.000381	0.000381	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—CCL2—age related macular degeneration	0.000368	0.000368	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000367	0.000367	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CCL2—age related macular degeneration	0.000366	0.000366	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—CCL2—age related macular degeneration	0.000365	0.000365	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000363	0.000363	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—CCL2—age related macular degeneration	0.00036	0.00036	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000354	0.000354	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—C3—age related macular degeneration	0.000354	0.000354	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—CCL2—age related macular degeneration	0.000341	0.000341	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—CCL2—age related macular degeneration	0.000335	0.000335	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—CD36—age related macular degeneration	0.000334	0.000334	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000329	0.000329	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000327	0.000327	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—CD36—age related macular degeneration	0.000325	0.000325	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—CD36—age related macular degeneration	0.000311	0.000311	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—VEGFA—age related macular degeneration	0.00031	0.00031	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—CCL2—age related macular degeneration	0.000309	0.000309	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—C3—age related macular degeneration	0.000305	0.000305	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—CCL2—age related macular degeneration	0.000298	0.000298	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—APOE—age related macular degeneration	0.000295	0.000295	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000288	0.000288	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—APOE—age related macular degeneration	0.000286	0.000286	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—APOE—age related macular degeneration	0.000284	0.000284	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—KDR—age related macular degeneration	0.000278	0.000278	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—C3—age related macular degeneration	0.000278	0.000278	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000277	0.000277	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—C3—age related macular degeneration	0.000275	0.000275	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—APOE—age related macular degeneration	0.000275	0.000275	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—C3—age related macular degeneration	0.000272	0.000272	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CD36—age related macular degeneration	0.000264	0.000264	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—APOE—age related macular degeneration	0.000259	0.000259	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—C3—age related macular degeneration	0.000257	0.000257	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—APOE—age related macular degeneration	0.000256	0.000256	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—KDR—age related macular degeneration	0.000254	0.000254	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—C3—age related macular degeneration	0.000253	0.000253	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—APOE—age related macular degeneration	0.000253	0.000253	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—KDR—age related macular degeneration	0.000251	0.000251	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.000251	0.000251	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—KDR—age related macular degeneration	0.000248	0.000248	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CETP—age related macular degeneration	0.000242	0.000242	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—APOE—age related macular degeneration	0.00024	0.00024	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CCL2—age related macular degeneration	0.000239	0.000239	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—APOE—age related macular degeneration	0.000236	0.000236	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—VEGFA—age related macular degeneration	0.000235	0.000235	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—KDR—age related macular degeneration	0.000235	0.000235	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—C3—age related macular degeneration	0.000233	0.000233	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—APOE—age related macular degeneration	0.000233	0.000233	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—KDR—age related macular degeneration	0.000231	0.000231	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—C3—age related macular degeneration	0.000225	0.000225	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCL2—age related macular degeneration	0.000218	0.000218	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—APOE—age related macular degeneration	0.000217	0.000217	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCL2—age related macular degeneration	0.000216	0.000216	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—KDR—age related macular degeneration	0.000213	0.000213	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCL2—age related macular degeneration	0.000213	0.000213	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—APOE—age related macular degeneration	0.000209	0.000209	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—C3—age related macular degeneration	0.000209	0.000209	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—KDR—age related macular degeneration	0.000205	0.000205	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCL2—age related macular degeneration	0.000201	0.000201	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCL2—age related macular degeneration	0.000198	0.000198	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—APOE—age related macular degeneration	0.000195	0.000195	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—KDR—age related macular degeneration	0.000191	0.000191	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCL2—age related macular degeneration	0.000183	0.000183	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCL2—age related macular degeneration	0.000176	0.000176	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCL2—age related macular degeneration	0.000164	0.000164	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VEGFA—age related macular degeneration	0.000153	0.000153	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CD36—age related macular degeneration	0.000146	0.000146	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VEGFA—age related macular degeneration	0.00014	0.00014	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000138	0.000138	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VEGFA—age related macular degeneration	0.000137	0.000137	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VEGFA—age related macular degeneration	0.000129	0.000129	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOE—age related macular degeneration	0.000128	0.000128	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VEGFA—age related macular degeneration	0.000127	0.000127	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VEGFA—age related macular degeneration	0.000117	0.000117	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000113	0.000113	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000105	0.000105	CbGpPWpGaD
